GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (LTS:0NF3) » Definitions » Dividends per Share

Paion Ag (LTS:0NF3) Dividends per Share : €0.00 (TTM As of Jun. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Paion Ag Dividends per Share?

Paion Ag's dividends per share for the six months ended in Jun. 2023 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2023 was 0.00. As of today, Paion Ag's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.


Paion Ag Dividends per Share Historical Data

The historical data trend for Paion Ag's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paion Ag Dividends per Share Chart

Paion Ag Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Paion Ag Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Paion Ag's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Paion Ag's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paion Ag's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Paion Ag's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Paion Ag's Dividend Yield % falls into.



Paion Ag Dividends per Share Calculation

Dividends paid to per common share.


Paion Ag  (LTS:0NF3) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Paion Ag's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2023 )/ EPS without NRI (Q: Jun. 2023 )
=0/ -1.35
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paion Ag Dividends per Share Related Terms

Thank you for viewing the detailed overview of Paion Ag's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Paion Ag (LTS:0NF3) Business Description

Traded in Other Exchanges
Address
Heussstrasse 25, Aachen, DEU, 52078
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.

Paion Ag (LTS:0NF3) Headlines

No Headlines